Thoracic Paravertebral Block for Postoperative Pain Management in PACU After VATS Surgeries: A Randomized Controlled Trial
Overview
- Phase
- N/A
- Intervention
- 0.4 ml/kg of 0.5% bupivacaine
- Conditions
- Pain, Postoperative
- Sponsor
- King Hussein Cancer Center
- Enrollment
- 81
- Locations
- 1
- Primary Endpoint
- Opioid requirement in the PACU
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This randomized controlled trial evaluated the efficacy of a thoracic paravertebral block (TPVB) in reducing opioid requirements and pain intensity in the PACU after video-assisted thoracoscopic surgery (VATS).
Detailed Description
This randomized controlled trial evaluated the efficacy of a thoracic paravertebral block (TPVB) in reducing opioid requirements and pain intensity in the PACU after video-assisted thoracoscopic surgery (VATS). Adult patients scheduled for elective VATS who meet the eligibility criteria will be randomized to either Arm: Arm 1: General anesthesia with TPVB; Arm 2: General anesthesia alone (control group). Primary Outcome: to assess Opioid requirement in the PACU
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult patients scheduled for elective VATS, ASA physical status II-III, BMI 19-40.
Exclusion Criteria
- •Patient refusal, coagulation disorders, contraindications to TPVB, chronic analgesic use, mental illness
Arms & Interventions
General anesthesia with TPVB
0.4 ml/kg of 0.5% bupivacaine injected into the thoracic paravertebral space
Intervention: 0.4 ml/kg of 0.5% bupivacaine
Outcomes
Primary Outcomes
Opioid requirement in the PACU
Time Frame: Opioid requirement assessed at 5 minutes, 15 minutes, 30 minutes post-PACU admission, and at PACU discharge (up to 4 hours)
Opioid requirement in the PACU, recorded as "yes" or "no."
Secondary Outcomes
- Pain intensity measured by Numeric Rating Scale -NRS(Pain intensity measured using the Numeric Rating Scale (NRS) at 5 minutes, 15 minutes, 30 minutes post-PACU admission, and at PACU discharge (up to 4 hours))